Showing results (51-60 of 59) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
Journal of Medicinal Chemistry|October 26, 2021
Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2ALars Wortmann, Nico Bräuer, Simon J Holton, et al.Journal of Medicinal Chemistry|December 20, 2018
Discovery and Characterization of the Potent and Highly Selective (Piperidin-4-yl)pyrido[3,2- d]pyrimidine Based in Vitro Probe BAY-885 for the Kinase ERK5Duy Nguyen, Clara Lemos, Lars Wortmann, et al.Breast Cancer Research and Treatment|October 30, 2007
DNA hypermethylation of PITX2 is a marker of poor prognosis in untreated lymph node-negative hormone receptor-positive breast cancer patientsInko Nimmrich, Anieta M Sieuwerts, Marion E Meijer-van Gelder, et al.Nucleic Acids Research|February 28, 2002
Tumour class prediction and discovery by microarray-based DNA methylation analysisPéter Adorján, Jürgen Distler, Evelyne Lipscher, et al.Journal for Immunotherapy of Cancer|November 14, 2023
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapyChristina Kober, Julian Roewe, Norbert Schmees, et al.Human Reproduction (Oxford, England)|May 29, 2026
ABHD2 activity is not required for the non-genomic action of progesterone on human spermMadison Edwards, Alexandra Amaral, Eve M Carter, et al.Nature Communications|June 11, 2021
A new molecular classification to drive precision treatment strategies in primary Sjögren's syndromePerrine Soret, Christelle Le Dantec, Emiko Desvaux, et al.Cell Chemical Biology|March 27, 2024
Discovery of YAP1/TAZ pathway inhibitors through phenotypic screening with potent anti-tumor activity via blockade of Rho-GTPase signalingKeith Graham, Philip Lienau, Benjamin Bader, et al.Arthritis & Rheumatology (Hoboken, N.J.)|January 26, 2021
Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune DiseasesGuillermo Barturen, Sepideh Babaei, Francesc Català-Moll, et al.Pageof 6